The GLP‑1 Effect: Rethinking Nutrition for a New Group of Consumers
As anti-obesity medication (AOM) makes weight loss easier and more efficient than ever before, it’s also driving another urgent need – for nutrient-dense foods that deliver essential nourishment and help offset known side effects.
The second webinar in our GLP-1 series explores the dietary needs and experiences of AOM users to get a better understanding of this rapidly growing consumer group.
This webinar is the second in our GLP‑1 series and dives into how these shifts translate into real consumer needs and innovation opportunities.
Join us to explore:
- The key changes in eating behaviour, preferences and routines
- What GLP‑1 means for nutrient density, protein needs and digestive comfort
- Where innovation is emerging – and where the biggest opportunities lie
- Real-life perspectives on how GLP‑1 impacts everyday eating and product expectations
By combining market insights with expert and consumer perspectives, this session offers a more nuanced view of how GLP‑1 is reshaping the role of food.
Sign up to gain fresh inspiration and actionable insights into this fast-evolving space.
📆 The GLP‑1 Effect: Rethinking Nutrition for a New Group of Consumers
- Date: 7 October 2026
- Time: 14:00 (CET)
- Duration: 45 minutes
ℹ️ Practical information
The webinar will be recorded and shared with you shortly after the live session. All information is intended for B2B customers, suppliers and distributors only and not for end consumers.
Line Rossen
Anne Sophie Pauli Rædkjær
She specialises in Commercial Innovation within FMCG from research to NPDs to Go-To market strategies.